Frontiers | Clinical Proteomics Profiling for Biomarker Identification Among Patients Suffering With Indian Post Kala Azar Dermal Leishmaniasis
Post Kala-Azar Dermal Leishmaniasis following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) for Primary Visceral Leishmaniasis in Bihar, India | PLOS Neglected Tropical Diseases
Leishmaniasis, cutaneous and visceral (oriental sore...
Leishmaniasis - Infectious Diseases - Merck Manuals Professional Edition
Leishmaniasis: Practice Essentials, Background, Pathophysiology
Interleukin-10 and the pathogenesis of human visceral leishmaniasis: Trends in Immunology
Challenges for management of post kala-azar dermal leishmaniasis and f | RRTM
Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis | Journal of Clinical Microbiology
Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods | SpringerLink
Frontiers | Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL)
The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: Does ultraviolet light (UVB) radiation play a role? - ScienceDirect
Mechanism of action of the anti-leishmanial drugs used in Post... | Download Scientific Diagram
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan: Molecular Therapy
Visceral leishmaniasis - Wikipedia
Immune responses in post kala-azar dermal leishmaniasis Chatterjee M, Sengupta R, Mukhopadhyay D, Mukherjee S, Dighal A, Moulik S, Sengupta S - Indian J Dermatol
Pathology and Mechanism of Disease in Kala-Azar and Post-kala-azar Dermal Leishmaniasis | SpringerLink
Impaired activation of lesional CD8+ T-cells is associated with enhanced expression of Programmed Death-1 in Indian Post Kala-azar Dermal Leishmaniasis | Scientific Reports
Leishmaniasis: Pathophysiology & Treatment - Dr. John Bartlett - Coursera